References
11/10/03 Weight Management
1. Bray GA. Obesity is a chronic, relapsing neurochemical disease. Int J Obes Relat Metab Disord. Epub ahead of print, 2003. www-us.ebsco.com/online/OnlineTitles.asp.
2. Urakawa H et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab. 88, 10:4673-6, 2003. http://jcem.endojournals.org.
3. Wlodek D, Gonzales M. Decreased energy levels can cause and sustain obesity. J Theor Biol. 225, 1:33-44, 2003. www.elsevier.com/locate/issn/0022-5193.
4. Bray GA. Obesity is a chronic, relapsing neurochemical disease. Int J Obes Relat Metab Disord. Epub ahead of print, 2003. www-us.ebsco.com/online/OnlineTitles.asp.
5. Peeters A et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Int Med. 138, 1:24-32, 2003. www.annals.org.
6. Zemel MB. Regulation of adiposity and obesity risk by dietary calcium: mechanism and implications. J Am Coll Nutr. 21, 2:146S-151S, 2002. www.jacn.org.
7. Teegarden D. Calcium intake and reduction in weight or fat mass. J Nutr. 133, 1:249S-251S, 2003. www.jacn.org.
8. Einsenstein J et al. High-protein weight-loss diets: are they safe and do they work? A review of the experimental and epidemiologic data. Nutr Rev. 60, 7 Pt 1:189-200, 2002. www.ilsi.org/publications/reviews.html.
9. Pittler MH et al. Chromium picolinate for reducing body weight: meta-analysis of randomized trials. Int J Obes Relat Metab Disord. 27, 4:522-9, 2003. www-us.ebsco.com/online/OnlineTitles.asp.
10. GR et al. A randomized, double masked, placebo-controlled study of the effects of chromium picolinate supplementation on body composition: a replication and extension of a previous study. Curr Ther Res. 59, 6:379-88, 1998. www.currenttherapeuticres.com.
11. Vincent JB. The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent. Sports Med. 33, 3:213-30, 2003. www.ncbi.nlm.nih.gov.
12. Talpur NA et al. "Antihypertensive and Metabolic Effects of Whole Maitake Mushroom Powder and its Fractions in Two Rat Strains." Mol Cell Biochem. 237:129-136, 2002. www.wkap.nl.
13. Dulloo AG et al. "Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity." Int J Obes Relat Metab Disord. 24, 2:252-8, 2000. www-us.ebsco.com/online/OnlineTitles.asp.
14. Dulloo AG et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-hour energy expenditure and fat oxidation in humans. Am J Clin Nutr. 70, 6:1040-5, 1999. www.ajcn.org.
15. Chantre P, Lairon D. "Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity." Phytomedicine. 9, 1:3-8, 2002. www.urbanfischer.de/journals/frame_template.htm?/journals/phytomed/phytmed.htm.
16. Hasegawa N et al. "Powdered green tea has antilipogenic effect on Zucker rats fed a high-fat diet." Phytother Res. 17, 5:477-80, 2003. www.interscience.wiley.com/jpages/0951-418X.
17. Sayama K et al. "Effects of green tea on growth, food utilization and lipid metabolism in mice." In Vivo. 14, 4:481-4, 2000. www.iiar-anticancer.org/index2.htm.
18. Yang M et al. "Green, oolong and black tea extracts modulate lipid metabolism in hyperlipidemia rats fed high-sucrose diet." J Nutr Biochem. 12, 1:14-20, 2001. www.elsevier.com/locate/jnutbio.
19. Moreno DA et al. "Inhibitory effects of grape seed extract on lipases." Nutrition. 19, 10:876-9, 2003. www.nutrition.org.
20. Hayashi T et al. "Ellagitannins from Lagerstroemia speciosa as activators of glucose transport in fat cells." Planta Med. 68, 2:173-5, 2002.
21. Judy WV et al. "Antidiabetic activity of a standardized extract (Glucosol) from Lagerstroemia speciosa leaves in Type II diabetics. A dose-dependence study." J Ethnopharmacol. 87, 1:115-7, 2003. www.elsevier.nl/inca/publications/store/5/0/6/0/3/5.
22. Liu F et al. "An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells." J Nutr. 131, 9:2242-7, 2001. www.nutrition.org.
23. Hayamizu K et al. "Effect of Garcinia cambogia extract on serum leptin and insulin in mice." Fitoterapia. 74, 3:267-73, 2003.
24. Ohia SE et al. "Safety and mechanism of appetite suppression by a novel hydroxycitric acid extract (HCA-SX)." Mol Cell Biochem. 238, 1-2:89-103, 2002. www.wkap.nl.
25. Ishihara K et al. "Chronic (-)-hydroxycitrate administration spares carbohydrate utilization and promotes lipid oxidation during exercise in mice." J Nutr. 130, 12:2990-5, 2000. www.nutrition.org.
26. Preuss HG et al. "Effect of Hydroxycitric Acid on Weight Loss, Body Mass Index and Plasma Leptin Levels in Human Subjects." FASEB Journal, 16:A1020, Abs. 742.16, 2002. www.fasebj.org.
27. Preuss HG et al. "Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview." J Med. 33, 1-4:247-64, 2002. http://www.medical-library.org/j_med.htm.
28. Colker CM et al. Effects of Citrus aurantium extract, caffeine and St. Johns wort on body fat loss, lipid levels and mood states in overweight healthy adults. Curr Ther Res. 60, 3:145-53, 1999. www.currenttherapeuticres.com.
29. "A patented phytonutrient for weight management by promoting lean body mass." Company research at Sabinsa Corp., 1999. www.sabinsa.com.
30. Sabinsa Corporation. Effect of ForsLean on body weight, body fat and lean body mass in overweight subjects. Unpublished. www.forslean.com
32. Birketvedt GS et al. Dietary supplementation with bean extract improves lipid profile in overweight and obese subjects. Nutrition. 18, 9:729-33, 2002. www.nutrition.org.
33. Tiberi, L. Evaluation of a dietary supplement for use, safety and effectiveness in reducing the intake of calories from complex carbohydrates as compared to placebo (double-blind test). EVIC Italia, 2001.
34. Kalman DS et al. "A randomized, double-blind, placebo-controlled study of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy, overweight adults." Curr Ther Res. 61, 7:2000. www.currenttherapeuticres.com.
35. Zenk JL et al. "The effect of 7-Keto Naturalean on weight loss: a randomized, double-blind, placebo-controlled trial." Curr Ther Res. 63, 4:2002. www.currenttherapeuticres.com.
36. Slater G et al, "Beta-hydroxy-beta-methylbutyrate (HMB) supplementation does not affect changes in strength or body composition during resistance training in trained men." Int J Sport Nutr Exerc Metab. 11, 3:384-96, 2001. www.humankinetics.com
37. Gallagher PM et al, "Beta-hydroxy-beta-methylbutyrate ingestion, part I: effects on strength and fat free mass." Med Sci Sports Exerc. 32, 12:2109-15, 2000. www.me-se.com
38. Kilduff LP et al. "Effects of creatine on isometric bench-press performance in resistance-trained humans." Med Sci Sports Exerc. 34, 7: 1176, 83, 2002. www.ms-se.com.
39. Lurz R, Fischer R. Aerztezeitschrift fur Naturheilverfahren. 39:12, 1998.
40. Muller DM et al. Effects of oral L-carnitine supplementation on in vivo long-chain fatty acid oxidation in healthy adults. Metabolism. 51, 11:1389-91, 2002.
41. Thom E, et al. Conjugated linoleic acid reduces body fat in healthy exercising humans. J Int Med Res. 29, 5:392-6, 2001. www.jimronline.net.
42. Smedman A, Vessby B. Conjugated linoleic acid supplementation in humans--metabolic effects. Lipids. 36, 8:773-81, 2001. www.aocs.org.
43. Belury MA et al. "The conjugated linoleic acid (CLA) isomer, t10c12-CLA, is inversely associated with changes in body weight and serum leptin in subjects with type 2 diabetes mellitus." J Nutr. 133, 1:257S-260S, 2003. www.nutrition.org.
44. Nagao K et al. "The 10trans,12cis isomer of conjugated linoleic acid suppresses the development of hypertension in Otsuka Long-Evans Tokushima fatty rats." Biochem Biophys Res Commun. 306, 1:134-8, 2003. www.naturesj.com/ejcn.
45. Kamphuis MM et al. "Effect of conjugated linoleic acid supplementation after weight loss on appetite and food intake in overweight subjects." Eur J Clin Nutr. 57, 10:1268-74, 2003. www.naturesj.com/ejcn.
46. www.clarinol.com
47. Schiller R et al. A Randomized, Double- Blind, Placebo- Controlled Study Examining the Effects of a Rapidly Soluble Chitosan Dietary Supplement on Weight Loss and Body Composition in Overweight and Mildly Obese Individuals. JANA. 4, 1:42-9, 2001. www.americanutra.com/jana.html.
48. Bokura H, Kobayashi S. "Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial." Eur J Clin Nutr. 57, 5:721-5 , 2003. www.naturesj.com/ejcn.
49. Zahorska-Markiewicz B et al. "Effect of chitosan in complex management of obesity." Pol Merkuriusz Lek. 13, 74:129-32, 2002.
50. Gallaher DD et al. "A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans." J Am Coll Nutr. 21, 5:428-33, 2002. www.jacn.org.
51. Kromhout D et al. "Physical activity and dietary fiber determine population body fat levels: the Seven Countries Study." Int J Obes Relat Metab Disord. 25, 3:601-6, 2001. www-us.ebsco.com/online/OnlineTitles.asp.
52. Saltzman E et al. "Effects of a cereal rich in soluble fiber on body composition and dietary compliance during consumption of a hypocaloric diet." J Am Coll Nutr. 20, 1:50-7, 2001. www.jacn.org.
53. Burton-Freeman B et al. Plasma cholecystokinin is associated with subjective measures of satiety in women. Am J Clin Nutr, 76, 3:659-67, 2002. www.ajcn.org.
54. Howarth NC et al. "Fermentable and nonfermentable fiber supplements did not alter hunger, satiety or body weight in a pilot study of men and women consuming self-selected diets." J Nutr. 133, 10:3141-4, 2003. www.nutrition.org.
55. Westerterp-Plantenga MS. "The significance of protein in food intake and body weight regulation." Curr Opin Clin Nutr Metab Care. 6, 6:635-8, 2003. www.co-clinicalnutrition.com.
56. Samaha FF et al. "A low-carbohydrate as compared with a low-fat diet in severe obesity." N Engl J Med. 348:2074-81, 2003. http://content.nejm.org.
57. Foster GD et al. "A randomized trial of a low-carbohydrate diet for obesity." N Engl J Med. 348:2082-90, 2003. http://content.nejm.org.
58. Allison DB et al. "A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial." Eur J Clin Nutr. 57, 4:514-22, 2003. www.naturesj.com/ejcn.
59. Nagasawa A et al. "Effects of soy protein diet on the expression of adipose genes and plasma adiponectin." Horm Metab Res. 34, 11-12:635-9, 2002. www.thieme.com/SID1990079910465/journals/pubid-388413336.html.
60. Bhathena SJ, Velasquez MT. "Beneficial role of dietary phytoestrogens in obesity and diabetes." Am J Clin Nutr. 76, 6:1191-201, 2002. www.ajcn.org.